ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE (Triumeq) Nursing Considerations

Join NURSING.com to watch the full lesson now.

Included In This Lesson

Outline

What is the Generic Name

ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE

What is the Trade Name for ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE

Triumeq

What is the Indication for ABACAVIR SULFATE, DOLUTEGRAVIR SODIUM, LAMIVUDINE

  • 1 INDICATIONS AND USAGE TRIUMEQ and TRIUMEQ PD are indicated for the treatment of HIV-1 infection in adults and in pediatric patients weighing at least 10 kg. Limitations of Use: ‚Ä¢ TRIUMEQ and TRIUMEQ PD alone are not recommended in patients with resistance ‚Äë associated integrase substitutions or clinically suspected integrase strand transfer inhibitor (INSTI) resistance because the dose of dolutegravir in TRIUMEQ and TRIUMEQ PD is insufficient in these subpopulations. See full prescribing information for TIVICAY (dolutegravir). TRIUMEQ and TRIUMEQ PD are a combination of dolutegravir (integrase strand transfer inhibitor [INSTI]), abacavir, and lamivudine (both nucleoside analogue reverse transcriptase inhibitors) indicated for the treatment of HIV-1 infection in adults and in pediatric patients weighing at least 10 kg. ( 1 ) Limitations of Use: ‚Ä¢ TRIUMEQ and TRIUMEQ PD alone are not recommended in patients with resistance-associated integrase substitutions or clinically suspected INSTI resistance because the dose of dolutegravir in TRIUMEQ and TRIUMEQ PD is insufficient in these subpopulations. See the dolutegravir prescribing information. ( 1 )

 

 

View Our Nursing Pharmacology Course

 

References: https://open.fda.gov/

 

Other Pharm Resources
Join NURSING.com to watch the full lesson now.
[NextGen]
[NextGen]